Recent formulation studies presented in the 2026 Formulation & Adjuvant Technology report suggest that biological products may be overcoming one of their biggest historical limitations: maintaining stability and efficacy throughout the supply chain and under real-world farming conditions. The findings are particularly relevant as growers, regulators and food companies increasingly demand sustainable alternatives to conventional crop protection products.

For years, the agricultural industry has recognized the potential of microbial biostimulants and biological crop protection products. The challenge was never proving efficacy in laboratories or greenhouses. The real obstacle was ensuring that living microorganisms remained viable from production to field application.

Crop Protection & Biologicals

Smart Co-Formulants Are Quietly Transforming Modern Crop Protection Through Next-Generation Formulation Science

tThe report highlights that many commercial microbial products have historically suffered from inconsistent microbial concentrations, contamination issues and poor shelf-life performance. As a result, growers often experienced variable field results despite promising scientific data.

Researchers point to three critical formulation factors:

One of the most important findings comes from a storage study involving Pseudomonas fluorescens, one of the most widely studied plant growth-promoting bacteria. The data showed that advanced formulations maintained significant microbial viability after approximately 240 days (eight months) at room temperature, even without refrigeration. Solid formulations retained about 1.06 × 10¹? CFU/g, while liquid formulations maintained approximately 5.16 × 10? CFU/ml.

According to the report's graph, microbial decline remained relatively limited compared with many traditional biological formulations, indicating that formulation technology is increasingly becoming the differentiating factor between success and failure.

Stability alone is not enough: delivery determines performance

The report emphasizes that field efficacy depends not only on microbial survival but also on how the product is delivered to the crop. Particle size, density and suspension behavior have emerged as critical variables for large-scale agricultural applications.

Large particles can create uneven dosing, clog application equipment and reduce seed coating quality. Liquid formulations face a different challenge: sedimentation. Without proper stabilization, microbial cells settle over time, leading to inconsistent application rates and reduced effectiveness.

Main barriers to large-scale biological adoption

The broader industry trend supports these developments. The report notes that increasing regulatory pressure to reduce chemical residues is accelerating investments in biopesticides, biostimulants, encapsulation technologies and controlled-release systems. Regulatory frameworks in Europe and other regions are also evolving to encourage biological innovation.

Technologies driving the next generation of biologicals

The report concludes that the future of biological products will depend less on discovering new microbial strains and more on the ability to formulate them for commercial agriculture. Companies that solve stability, logistics and application challenges may finally unlock the full potential of biologicals at global scale.